Readify

Virginia's 2014 Medicaid expansion blocked

Dopesick

Virginia’s 2014 Medicaid expansion blocked was a legislative defeat with consequences extending well beyond the statehouse: as opioid-related harms mounted, Virginia turned away federal funding and health coverage that could have helped low-income residents obtain treatment. The book presents the defeat not as an isolated partisan maneuver but as part of a larger failure to connect economic distress, insurance access, and addiction care.

Background: an epidemic amid economic decline

The proposal came against a backdrop of weakened employment and rising need. In rural Virginia towns including Big Stone Gap, Lebanon, and St. Charles, Purdue representatives promoted OxyContin to family doctors, a group that by 2000 had become the drug’s largest single prescriber group. These towns already had high per-capita numbers of dislocated workers and work-related disability claims. In Galax, factory closures and further downsizing accompanied the movement of sewing and furniture production to lower-wage countries after the North American Free Trade Agreement and China’s entry into the World Trade Organization.

The book links those economic conditions to the epidemic without reducing it to a single cause. In Martinsville and surrounding Henry County, unemployment rose above 20 percent, food-stamp claims more than tripled, and disability rates increased by 60.4 percent. Its broader account identifies the collapse of work, rising disability, and an expanding supply of painkillers as interacting forces. Against that background, access to insurance and treatment was not a peripheral policy question: it concerned whether people in distressed communities could reach care as well as whether opioid exposure and economic insecurity were deepening together.

The legislative defeat

In June 2014, a year before the first fentanyl spike described in the account, Virginia’s Republican-controlled legislature shut down the Democratic governor’s Medicaid expansion proposal. The decisive political turn came when Democratic coalfields senator Phillip P. Puckett abruptly resigned, giving Republicans a majority capable of defeating expansion. Puckett represented a region of Appalachia among the state’s hardest hit by the epidemic, and his departure left no Democratic legislator west of Roanoke.

The resignation carried allegations about personal and political benefits. One alleged motivation was to make Puckett’s lawyer daughter eligible for a judgeship, although Senate policy barred judicial appointments of relatives. Another was to enable Puckett to obtain a position with the commission overseeing economic-development investments from Virginia’s share of the tobacco settlement. He later withdrew from consideration for that tobacco-related post, citing family matters. A six-month federal investigation into corruption claims went nowhere; the book reports the allegations and the unsuccessful investigation, not a finding that they were proven.

What expansion could have funded

The immediate stakes were substantial. Virginia was forgoing $6.6 million a day in federal funds and coverage for 400,000 low-income residents. In states that adopted expansion, Medicaid became a central tool in responding to the epidemic: it paid for treatment, counseling, and addiction medications while filling long-standing gaps in care. It also extended coverage to 1.3 million people with addiction who were not poor enough to qualify for Medicaid under previous rules but could not afford private insurance.

The state’s treatment landscape shows why insurance mattered, while also illustrating that coverage alone would not resolve every barrier. Tess Henry’s family found a private facility that accepted patients receiving medication-assisted treatment, but its $20,000 bill required private insurance and a $6,500 deductible paid by her father. Later, buprenorphine medication was partly covered by insurance, yet appointments with her addiction doctor were cash-only: $700 up front and $90 to $100 for each follow-up, as many as four visits a month. These experiences are not presented as consequences of the 2014 vote alone; they make visible the costs and access problems within which the expansion debate unfolded.

Other examples expose the fragility of care for people without reliable coverage. A fifty-four-year-old teacher in southwestern Virginia had gone without insurance for decades and relied on free care at Remote Area Medical events and visits to the Health Wagon’s mobile unit. Since Virginia had not approved the Affordable Care Act Medicaid expansion, she sought her family doctor only when she was nearly dying, paying a discounted cash rate of $63. Her situation places the policy choice in the practical terrain of delayed care, limited resources, and patchwork provision.

Treatment access and public priorities

The account also contrasts the limited treatment infrastructure with the resources devoted to corrections. Roanoke lacked comparable local inpatient treatment; available options included short-term detoxification and a private facility that accepted only insurance and cash, charged about $20,000 for a twenty-eight-day stay, and did not permit maintenance medication. The Hope Initiative later assembled a five-page spreadsheet listing thirty-six rehabilitation and aftercare providers, matching options to patients’ finances and available beds. Its volunteers helped people navigate an intricate system, but a referral list could not create affordable coverage or local treatment capacity.

Roanoke Police Chief Chris Perkins argued for redirecting some of the savings from diverting people from jail into treatment. He pointed to a state corrections budget of roughly one billion dollars, compared with the few million dollars needed for inpatient care, and noted that two hundred of the city jail’s eight hundred beds were typically empty. In his account, corrections budgets and the political influence of sheriffs were easier to sustain than treatment spending. That argument sharpens the significance of the Medicaid defeat: the book depicts both a refusal to expand a major health-care funding stream and a wider public priority in which incarceration could command resources that treatment struggled to obtain.

Significance

The defeat left Virginia outside a policy approach that other states were using to finance addiction treatment, counseling, and medications. It also became part of a continuing access problem: local advocates and clinicians worked to connect people with care, while waiting lists, cash-only practices, eligibility limits, and scarce inpatient options obstructed that work. The book’s account therefore treats the 2014 vote as both a specific partisan reversal and an expression of a structural divide. Economic hardship and opioid supply helped drive the crisis, while decisions about insurance and public spending shaped how much support was available to respond.